Skip to main content



Friday, June 19, 2020 

Bureau Veritas (BV) is working with Ponant, a cruise company with a fleet of 11 smaller-scale ships combining latest technology and respect for the environment, to help implement effective infection prevention measures.

Ponant will benefit from the 'Restart your Business with BV' suite of solutions developed for passenger ship clients. ‘Restart your Business with BV’ for passenger ships meets the specific requirements of this market addressing health risks, as posed by Covid-19 and other infections. It provides procedures and measures to protect passengers, company personnel and other stakeholders as operations are resumed, helping ensure that appropriate health and safety standards are put in place.

Matthieu de Tugny, EVP BV Marine and Offshore, said: "Bureau Veritas has been working across many industries to help develop new standards both with - and for, clients, in order to provide assurance to stakeholders and regulators that the risk of infection are being mitigated effectively. This service developed for passenger ships includes a framework of standards and best practices. Compliance with which is demonstrated by our new Bureau Veritas label, SafeGuard. The intention is that the label is visible and helps provide confidence to all onboard and in related operations ashore."

The SafeGuard label is awarded when it can be satisfactorily certified that the operator has addressed health, safety and hygiene requirements, has properly implemented necessary procedures, has trained the crew and all employees on board and has, as well, agreed procedures with ports and terminals for port operations.

Ponant COO Frédéric Gallois said: "The small size of our vessels, the medical infrastructure and teams on board, our protocols and the professionalism of our crews ensured that there were no cases of Covid-19 contamination throughout the Ponant’s fleet. To prepare for the resumption of our activity, we are pleased to collaborate with Bureau Veritas to deploy this SafeGuard label highlighting the excellence of our protocols.”

Reader Comments (0)

There are currently no comments on this article. Why not be the first and leave your thoughts below.

Leave Your Comment

Please keep your comment on topic, any inappropriate comments may be removed.

Return to index